Close Menu

Caris

The trial is using technologies from Caris Life Sciences and George Mason University's Center for Applied Proteomics and Molecular Medicine to create proteomic profiles to determine which therapies work best for each individual patient.

Life Technologies, the Translational Genomics Research Institute, and US Oncology plan to sequence tumor-normal genomes for 14 breast cancer patients to determine whether this sequencing can be used to better tailor treatments.

The Caris Registry will contain information about cancer patients using the company's Target Now suite of molecular profiling services, including the genetic profile of patients' tumors, their cancer treatment history, and their clinical outcome.

Movers & Shakers

Premium

William Wallen, Jonathan Knowles, Jon Burrows, Jenny Heidbrink, Sheeno Thyparambil

Pairings

Premium

Jerry Martino, Paul Maier, Chris Emery, Lony Lim

Movers & Shakers

Premium

Jerry Martino

Movers & Shakers

Premium

Marijn Dekkers, Marc Casper, Stephen DeFalco, Steve West, Thomas Spalding, Thomas Vogel, Alan Rosenson

Pages

Researchers tie a variant in ADAMTS3 to breathing difficulties in dissimilar dog breeds, according to Discover's D-brief blog.

The Japan Times reports that researchers sequenced the genome of a woman who lived during the Jomon period.

Parents of children with rare genetic disease have to contend with shifts in the interpretation of genetic variants, the Wall Street Journal reports.

In Science this week: single-nucleus RNA sequencing of brain tissue from individuals with autism, and more.